Michael is a specialist patent attorney in the in the pharmaceutical field and has more than 20 years of experience at all stages of a product, from early phase discovery to defending marketed pharmaceutical products. Michael acts for a wide range of clients including multinationals, SMEs, universities and research organisations.
Prior to joining HGF Michael worked "in-house" as a patent attorney for 13 years for AstraZeneca and use this experience and insight to advise clients and develop IP strategies that are focused on their commercial objectives.
His work covers patent drafting, global prosecution, patent term extensions and SPCs, freedom to operate analysis and opinions, regulatory exclusivity as well as significant experience in IP due diligence evaluation. Michael also handles EPO oppositions and appeals for his clients.
Physics (First Class Honours)
June 27th 2022
May 10th 2021
March 3rd 2020
June 27th 2019
March 14th 2019
The European Patent Office (EPO) has announced that revised Official Fees will apply to payments made on or after Monday 1st April 2024. The majority of fees will increase by …Read article
HGF are proud Event Partners of CAR-TCR Europe, which is due to go ahead from 27th – 29th February at ExCeL, Royal Victoria Dock in London. This is the European hub …Event details
Porter’s Five Forces model  is just one example of a convenient model for exploring and understanding the forces at play in a competitive marketplace. Michael Porter’s Five Forces model …Read article
In an unprecedented move, the MHRA has approved a CRISPR gene editing therapy ‘Casgevy’ for the treatment of sickle cell disease and beta-thalassaemia in patients with recurrent vaso-occlusive crises. The Casgevy …Read article
HGF is pleased to invite you to our upcoming German-language seminar on “Invention and patent searches in public databases” in Salzburg and Dresden. The seminar will showcase how public databases …Event details
“Medical devices and bioinformatics / AI diagnostic feedback – law and practice in Europe and Japan” The EPC does not allow ‘medical use’ claims for medial devices. So how do …Event details
A patent is a legal right that enables the patent holder to prevent others from making and using their invention in the country where the patent is granted. To many …Read article
Order of the classifications listed on the front of a patent and why it matters? On 1 June 2023, ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE lodged a statement of revocation of …Read article
If you would like to discuss how HGF could help you, contact one of our IP specialists.